Maplight Therapeutics, Inc. · NASDAQ:MPLT

Catalyst4, Inc. reported a 49.90% stake in Maplight Therapeutics, Inc. (Schedule 13D/A)

Event Aug 14, 2026 · Filed Aug 18, 2026

Catalyst4, Inc. reported a 49.90% stake in Maplight Therapeutics, Inc., 27,536,011 shares, with active intent on Aug 14, 2026. Filed Aug 18, 2026 (Schedule 13D/A).

Stake
49.90%
Shares
27,536,011
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Catalyst4, Inc.49.90%27,536,011
Robert Brown49.90%27,536,011
Ekemini Riley49.90%27,536,011
Mark Vorsatz49.90%27,536,011

Source

View original at SEC

Related